SPIMACO announces the launch of SPIMACO Bio, a new subsidiary focused on biologic, genetic, and cell-based therapies, supporting advanced pharmaceutical manufacturing, knowledge transfer, and sustainable growth in the Kingdom, pending regulatory approvals.